Purpose: Our purpose was to assess whether in vitro fertilization (IVF)-embryo transfer (ET
to undergo capacitation, acrosome reaction, and oocyte penetration in vitro (1, 2) . The value of this assay in predicting outcome for human in vitro fertilization (IVF)-embryo transfer (ET) is extremely controversial (3) (4) (5) (6) . Several investigators have suggested that the predictive value for failed IVF may be greater in couples with failing HEPA scores and unexplained or tubal as opposed to male-factor infertility (7, 8) .
Intracytoplasmic sperm injection (ICSI) techniques clearly represent a major advance in achieving conception for those couples with severe male-factor infertility (9, 10) . The benefit of this approach has not been as well established in patients with less severe sperm function abnormalities. The role of HEPA in determining which sperm samples may be best treated with ICSI in couples who are candidates for IVF-ET has also not been established.
In this prospective, randomized investigation, we have attempted to assess the necessity for assisting fertilization by using ICSI in couples undergoing IVF-ET with sperm samples demonstrating a failing HEPA score but with otherwise normal semen analysis parameters.
INTRODUCTION
The zona-free hamster egg penetration assay (HEPA) has been used to predict defects in the ability of sperm ' 
MATERIALS AND METHODS
This investigation was a prospective, randomized trial. HEPA was performed in our program as part of a routine evaluation prior to IVF-ET. The study population consisted of 20 consecutive IVF candidate couples with semen analyses demonstrating normalborderline parameters and HEPA with failing scores as described below. Candidates were patients with the following parameters on two semen analyses each performed after 48-136 hr of abstinence and at least 4 weeks apart: concentration, ^20 X 106/ml; motility S40% (grades 2-3); and morphology, ^35% normal forms by World Health Organization criteria.
The zona-free HEPA was performed with sperm samples which were Percoll (Pharmacia, Upsala, Sweden)-washed and incubated overnight in BWW-buffered medium. Twenty cryopreserved and subsequently thawed zona-free hamster eggs (Fertility Technologies, Inc., Natick, MA) were added to the samples for a 4-hr incubation at 37°C under standard culture conditions. Sperm binding and oocyte penetration were subsequently assessed, A penetration score of less than 15% was considered to be failing. Sperm samples from donors with established fertility were used in parallel for assay validation. The assay was considered valid if the control sample penetration score was greater than 50%.
The indications for IVF-ET in this patient population are displayed in Table I . All patients had a circulating serum follicle-stimulating hormone (FSH) level of less than 10 mlU/ml and an estradiol (E2) level of less than 80 pg/ml on cycle day 2 or 3. Patients underwent gonadotropin down-regulation with a gonadotropinreleasing hormone agonist (Lupron; TAP Pharmaceuticals, Waukegan, IL), 1.0 mg subcutaneously daily, initiated during the midluteal phase. After 10 days of agonist therapy and once serum E2 levels were noted to be less than 50 pg/ml, the dose was decreased to 0.5 mg daily and gonadotropin stimulation (Metrodin or Fertinex; Serono Laboratories, Randolph, MA) was initiated at a dose ranging from 225 to 450 IU im daily. Follicular development was monitored with serial ultrasound examinations and serum E2 and progesterone (P4) levels with gonadotropin doses adjusted as appropriate. Human chorionic gonadotropin (Profasi, Serono), 10,000 U intramuscularly, was administered when at least two follicles were greater than 18 mm in mean diameter, a serum E2 level of > 500 pg/ mL, and a P4 level of ^ 1.9 mg/ml were noted.
Oocytes were collected by transvaginal ultrasoundguided aspiration techniques using intravenous sedation and cultured in either protein-supplemented human tubal fluid (Irvine Scientific, Irvine, CA) or Basal-XI (Biocare Corp., San Diego, CA) medium prepared as microdrops under sterile mineral oil (Squibb, Princeton, NJ).
After approved informed consent was obtained from each couple, all morphologically normal metaphase-II oocytes aspirated from each patient were randomly divided by the embryologist into two equal groups on which either ICSI or standard insemination techniques were performed. ICSI was undertaken on 126 oocytes in group I by introducing a single motile sperm into each oocyte by filter-isolated mouth pressure in glass depression slides using Nomarski optics. This procedure was performed 1-6 hr following oocyte aspiration. Group II consisted of 138 oocytes on which conventional insemination was performed with 10,000-20,000 motile sperm added to microdrops of medium each of which contained 1-6 oocytes. Unequal numbers in the overall groups stem from the fact that some oocytes initially felt to be mature and randomized to group I were not deemed to be so at the time of ICSI.
Oocytes were checked for the appearance of pronuclei (PN) 16-18 hr and for embryo cleavage 40-42 hr post insemination. Normal fertilization (two PN) and cleavage rates were assessed for both groups. Data were analyzed by paired t tests and chi-square analysis where appropriate. A P value of less than 0.05 was considered to be statistically significant.
RESULTS
The mean precycle sperm parameters and HEPA scores are displayed in Table II . The mean ± standard error of the mean HEPA score of 3.8 ± 1.6% for the patients was well below the passing level of 15%. No penetration at all was appreciated in 10 patients. Basic clinical data regarding controlled ovarian stimulation and oocyte aspiration are presented in Table III . These patients were relatively young and responded well to stimulation, resulting in a high enough number of mature oocytes obtained per aspiration to result in at least four oocytes to be allocated to each group for each patient.
Normal fertilization and cleavage rates (2-to 4-cell stage) were similar between the two groups (Fig. 1) . Fertilization rates were higher with ICSI than standard insemination in only four patients. The converse was true in only two patients. Fertilization rates of less than 50% were noted in 20% of ICSI procedures and 10% of standard insemination procedures. These differences were not statistically significant. Due to transfer and cryopreservation of embryos pooled from both groups in several patients, comparative pregnancy rates for each group cannot be calculated. 
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DISCUSSION
In this study, we have demonstrated that ICSI is not beneficial for IVF-ET when sperm samples demonstrate a failing HEPA score but have otherwise normal or minimally compromised parameters on traditional semen analyses. Neither fertilization nor cleavage rates were enhanced.
The role of the HEPA in predicting the benefit of ICSI over conventional insemination in IVF-ET has not, to our knowledge, been previously addressed. Chen and colleagues have previously reported that in normal males, the rate of sperm penetration by subzonal insertion of sperm was significantly lower with failing HEPA results (11) . Vazquez-Levin el al. had demonstrated that failing HEPA scores had no predictive value for success with partial zona pellucida drilling techniques (12) .
The fertility potential for men with normal semen analyses, yet failing HEPA scores, is somewhat controversial. Investigators have reported that a high correlation exists between failed IVF and failing HEPA scores primarily in couples with unexplained infertility or tubal-factor infertility and partners with normal semen analyses (7, 8) . Kuzan and colleagues have demonstrated little or no correlation between HEPA scores and IVF cycle outcome (4) . Others have shown that spontaneous conception also correlates with HEPA results (13, 14) . However, these findings have been refuted by O'Shea et al. (15) .
The high incidence of false-positive results represents one of the weaknesses of the HEPA assay (12, 16, 17) . A variety of techniques including Test-Yolk buffer, pentoxifylline, and follicular fluid incubation as well as alteration of time and temperature has been used in an effort to decrease the incidence of false/positive results and enhance the sensitivity of the assay (6, (18) (19) (20) (21) (22) (23) . These techniques were not used in the HEPA employed in this investigation. Their use may have theoretically improved the poor predictive value associated with this study. Similarly, the relatively small sample size may have limited the power of this investigation resulting in a type-II error. A larger-scale investigation would clearly be of value.
In summary, therefore, the HEPA provides little indication for the need for ICSI in couples with otherwise normal semen analysis parameters. These findings do not address the issue of whether a failing HEPA score suggests a need for IVF-ET per se in couples with otherwise unexplained infertility. However, the value of the HEPA as currently performed in the standard evaluation of the patient with infertility must be seriously questioned.
